Completed NA INTERVENTIONAL 2-arm NCT03269617

PHAGE Study: Bacteriophages as Novel Prebiotics

PreforPro: A Randomized, Placebo Controlled Crossover Study

Sponsor: Colorado State University

Conditions Gastrointestinal Disorder, Functional

Interventions Bacteriophage mixture Placebo Control

Updated 6 times since 2017 Last updated: Apr 2, 2019 Started: Oct 1, 2016 Primary completion: May 30, 2017 Completion: May 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gastrointestinal Disorder, Functional, this trial is completed. The trial is conducted by Colorado State University and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Sep 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Colorado State University
George Mason University
Metabiomics Corp

Data source: Colorado State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.